U.S. federal trademark · Serial No. 79417433 · Reg. No. 8155672
Research and development in the pharmaceutical and biotechnology fields; research and development of artificial intelligence (AI) and machine learning-based software platforms to identify targets for therapeutic development, specifically in the field of cardiometabolic disease; medical research concerning modulation of identified druggable targets using small molecules, antibodies or other modalities for the treatment of cardiometabolic disease
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.